Epidemiology — MCQs

Epidemiology Indian Medical PG Practice Questions and MCQs

Question 291: Demographic transition is characterized by a shift in population dynamics. What factor is primarily responsible for initiating this transition?

A. Increase in fertility rates
B. Decrease in death rates (Correct Answer)
C. Increase in death rates
D. Stagnation of birth and death rates

Explanation: **Explanation:** The **Demographic Transition Model** describes the historical shift from high birth and death rates to low birth and death rates as a country develops. **Why Option B is correct:** The transition is primarily initiated by a **decrease in death rates** (Stage 2: Early Expanding). This decline is driven by improvements in public health, sanitation, food security, and medical advancements (e.g., vaccines and antibiotics). Because death rates fall while birth rates remain high, this stage is characterized by a "population explosion." The decline in mortality always precedes the decline in fertility in the demographic cycle. **Why incorrect options are wrong:** * **Option A:** An increase in fertility rates is not a feature of the demographic transition; birth rates are either high and stable (Stage 1) or declining (Stages 3 and 4). * **Option C:** An increase in death rates would indicate a demographic regression or a catastrophic event (famine/war), which is the opposite of the transition toward development. * **Option D:** Stagnation of both rates occurs in Stage 1 (High Stationary) and Stage 4 (Low Stationary), but it does not *initiate* the transition. **High-Yield NEET-PG Pearls:** * **Stage 1 (High Stationary):** High Birth Rate (BR), High Death Rate (DR). * **Stage 2 (Early Expanding):** DR begins to decline; BR remains high. **India is currently transitioning out of the late phases of Stage 3.** * **Stage 3 (Late Expanding):** DR continues to fall; BR begins to decline. * **Stage 4 (Low Stationary):** Low BR, Low DR. * **Stage 5 (Declining):** BR falls below DR (e.g., Germany, Japan, Hungary). * **Key Indicator:** The "Natural Increase" is the difference between the Birth Rate and the Death Rate.

Question 292: Which of the following methods is used for epidemiological studies of H. Pylori?

A. Urea-breath test
B. Serological markers (Correct Answer)
C. Culture
D. Gastric-biopsy urease test

Explanation: **Explanation:** The choice of a diagnostic test for *H. pylori* depends on whether the goal is clinical management or **epidemiological surveillance**. **Why Serological Markers are correct:** In epidemiological studies, the objective is to determine the prevalence or incidence of an infection within a large population. **Serology (ELISA for IgG antibodies)** is the preferred method because it is non-invasive, inexpensive, and does not require specialized equipment or fasting. Most importantly, it reflects "ever-infected" status, making it ideal for screening large groups to understand the burden of disease in a community. **Analysis of Incorrect Options:** * **Urea Breath Test (UBT):** While UBT is the "Gold Standard" non-invasive test for clinical diagnosis and confirming eradication, it is too expensive and logistically demanding (requires isotope-labeled urea and breath collection kits) for large-scale population-based epidemiological surveys. * **Culture:** This is highly specific but has low sensitivity due to the fastidious nature of the bacteria. It requires an invasive endoscopy and is primarily used for antibiotic sensitivity testing in treatment-resistant cases. * **Gastric-biopsy Urease Test (RUT):** This is the "Invasive Gold Standard" for rapid clinical diagnosis. However, because it requires an upper GI endoscopy, it is unethical and impractical for studying healthy populations in the community. **High-Yield Pearls for NEET-PG:** * **Best screening test for populations:** Serology. * **Best non-invasive test for diagnosis/follow-up:** Urea Breath Test (UBT). * **Most sensitive/specific invasive test:** Gastric Biopsy with Histopathology. * **Test of choice for eradication confirmation:** UBT (performed 4 weeks after treatment). * *H. pylori* is a Group 1 Carcinogen associated with Gastric Adenocarcinoma and MALToma.

Question 293: How frequently should a health worker visit all houses in their area to check for malaria cases?

A. Weekly
B. Fortnightly (Correct Answer)
C. Monthly
D. Yearly

Explanation: **Explanation:** The correct answer is **Fortnightly (Option B)**. This frequency is a cornerstone of the **Active Case Detection (ACD)** strategy under the National Vector Borne Disease Control Programme (NVBDCP) for Malaria. **Why Fortnightly?** The primary objective of ACD is to identify fever cases, collect blood smears (thick and thin), and provide presumptive treatment. The fortnightly (once every 14 days) interval is strategically chosen based on the **incubation period of Malaria** (typically 10–14 days for *P. falciparum* and *P. vivax*). By visiting every 14 days, the health worker ensures that any new infection that has progressed to the symptomatic stage is detected and treated before the patient can become a source of further transmission to mosquitoes. **Analysis of Incorrect Options:** * **Weekly (A):** While more frequent, it is logistically demanding and unnecessary given the parasite's incubation period. * **Monthly (C):** Too infrequent. A patient could remain symptomatic and infectious for weeks, leading to local outbreaks and increased morbidity. * **Yearly (D):** This is irrelevant for acute infectious disease surveillance and is typically used for chronic disease prevalence surveys. **High-Yield Clinical Pearls for NEET-PG:** * **ACD vs. PCD:** Active Case Detection is done by health workers via house-to-house visits (Fortnightly). Passive Case Detection (PCD) occurs when a patient voluntarily visits a health facility. * **Annual Parasite Incidence (API):** The most sensitive indicator for measuring the malaria burden in a community. * **Drug of Choice:** For *P. vivax*, it is Chloroquine (3 days) + Primaquine (14 days). For *P. falciparum*, it is ACT (Artesunate Combination Therapy) + single dose Primaquine on Day 2. * **Surveillance Indicator:** The **Annual Blood Examination Rate (ABER)** should ideally be **>10%** to ensure effective surveillance.

Question 294: What is the denominator in the calculation of sensitivity?

A. Total number of healthy individuals
B. Total number of diseased individuals (Correct Answer)
C. Total number of individuals with positive test results
D. Total number of individuals with negative test results

Explanation: ### Explanation **Sensitivity** is defined as the ability of a test to correctly identify those who have the disease. It represents the proportion of "true positives" among all individuals who actually possess the condition. **1. Why Option B is Correct:** The formula for sensitivity is: $$\text{Sensitivity} = \frac{\text{True Positives (TP)}}{\text{True Positives (TP)} + \text{False Negatives (FN)}} \times 100$$ The denominator $(TP + FN)$ represents the **total number of diseased individuals** in the population being tested. Therefore, sensitivity measures how "sensitive" the test is at picking up the disease when it is truly present. **2. Why Other Options are Incorrect:** * **Option A:** The total number of healthy (non-diseased) individuals is the denominator for **Specificity**. * **Option C:** The total number of individuals with positive test results $(TP + FP)$ is the denominator for **Positive Predictive Value (PPV)**. * **Option D:** The total number of individuals with negative test results $(TN + FN)$ is the denominator for **Negative Predictive Value (NPV)**. **Clinical Pearls for NEET-PG:** * **SNOUT:** A highly **S**ensitive test, when **N**egative, rules **OUT** the disease (used for screening). * **SPIN:** A highly **SP**ecific test, when **P**ositive, rules **IN** the disease (used for confirmation). * **Fixed Property:** Sensitivity and Specificity are inherent properties of a test and do not change with the prevalence of the disease (unlike PPV and NPV). * **Ideal Screening Test:** Should have high sensitivity to ensure minimum "False Negatives."

Question 295: What is the percentage of visual impairment for a disability certificate if vision is 4/60?

A. 100%
B. 75% (Correct Answer)
C. 40%
D. 30%

Explanation: In India, the assessment of visual disability for certification follows the guidelines issued by the Ministry of Social Justice and Empowerment (Gazette Notification 2018). The percentage of disability is determined based on the **best-corrected visual acuity (BCVA)** in the better eye and the worse eye. ### **Explanation of the Correct Answer** **Option B (75%)** is correct because, according to the standardized disability table, a visual acuity of **3/60 to 6/60** in the better eye (with best correction) corresponds to **75% visual impairment**. This falls under the category of "Severe Visual Impairment." ### **Analysis of Incorrect Options** * **Option A (100%):** This is reserved for "Total Blindness," where the visual acuity is less than 3/60 to no light perception (PL-) in the better eye, or a field of vision less than 10 degrees. * **Option C (40%):** This is the minimum criteria to be eligible for disability benefits. It typically corresponds to a BCVA of 6/18 to 6/36 in the better eye. * **Option D (30%):** This represents mild visual impairment (BCVA 6/12 to 6/18) and does not meet the legal threshold for "benchmark disability" (which is ≥40%). ### **High-Yield Clinical Pearls for NEET-PG** * **Benchmark Disability:** A person must have at least **40%** disability to avail of government reservations and benefits. * **NPCBVI Criteria:** Under the National Programme for Control of Blindness and Visual Impairment, blindness is defined as VA **<3/60** in the better eye (Snellen's chart). * **Low Vision:** VA between **6/18 and 3/60**. * **Field of Vision:** If the field of vision is <10° in the better eye, it is considered 100% disability regardless of visual acuity.

Question 296: Which of the following statements regarding Japanese Encephalitis is true?

A. An epidemic is declared if there are 2-3 cases in a village. (Correct Answer)
B. 70% of cases are reported from infants.
C. The ratio of clinical apparent to non-apparent infections is 1:100.
D. Mosquito bite is always associated with the disease.

Explanation: ### Explanation **1. Why Option A is Correct:** Japanese Encephalitis (JE) is a disease of significant public health importance due to its high case fatality rate and potential for permanent neurological sequelae. In the context of public health surveillance in India, JE is considered an "uncommon" event in a stable population. Therefore, the threshold for declaring an epidemic is very low: **2 or more cases in a village** are sufficient to trigger an epidemic response and intensive vector control measures. **2. Why the Other Options are Incorrect:** * **Option B:** JE primarily affects children, but it is rare in infants (<1 year). This is due to the presence of **maternally derived antibodies** and lower environmental exposure. The peak incidence is usually seen in the **5–15 years** age group. * **Option C:** The ratio of clinical (apparent) to subclinical (inapparent) infections is much wider, typically ranging from **1:300 to 1:1000**. This means for every one patient showing symptoms, hundreds are infected but remain asymptomatic, acting as a reservoir for the virus. * **Option D:** While JE is transmitted by the *Culex* mosquito, a bite does **not** always lead to disease. Most infections are asymptomatic (as noted in Option C). The development of clinical disease depends on host immunity and viral load. **3. High-Yield Clinical Pearls for NEET-PG:** * **Vector:** *Culex tritaeniorhynchus* (breeds in stagnant water/paddy fields). * **Reservoir/Amplifier Host:** **Pigs** (essential for the virus to reach high titers). * **Dead-end Hosts:** Humans and Horses (viremia is too low to infect mosquitoes). * **Vaccine:** Live attenuated **SA-14-14-2** (most common in India) or killed (JENVAC). Under the Universal Immunization Programme (UIP), it is given at 9 months and 16–24 months in endemic districts. * **Seasonality:** Post-monsoon period.

Question 297: A study is designed to evaluate the relationship between smoking exposures during the postpartum period and the child's birth weight after delivery. What type of study is this?

A. Case control
B. Prospective cohort (Correct Answer)
C. Cross sectional
D. Clinical trial

Explanation: ### Explanation **Why Prospective Cohort is Correct:** In this study design, the researcher starts with a group of individuals (postpartum mothers) who are currently exposed to a factor (smoking) and follows them over time to observe the development of an outcome (child’s weight/growth). * **Directionality:** It moves from **Cause (Exposure) to Effect (Outcome)**. * **Timing:** Since the exposure is measured *before* the outcome is fully assessed over the postpartum period, it is prospective. * **Key Concept:** Cohort studies are the gold standard for determining **Incidence** and **Relative Risk**. **Why Other Options are Incorrect:** * **A. Case-Control:** This would start with the outcome (e.g., children who already have low birth weight) and look *backwards* in time to see if their mothers smoked. It moves from Effect to Cause. * **C. Cross-sectional:** This provides a "snapshot" where exposure and outcome are measured at the same single point in time. it cannot establish a temporal relationship (which came first). * **D. Clinical Trial (RCT):** This involves an intervention. It would be unethical to intentionally assign mothers to a "smoking group" to see the effect on their children. **High-Yield Clinical Pearls for NEET-PG:** * **Cohort Study:** Best for rare exposures; can study multiple effects of a single exposure. * **Case-Control Study:** Best for rare diseases; uses **Odds Ratio** as the measure of association. * **Temporal Association:** The strongest criteria of Bradford Hill's criteria for causality, best demonstrated by prospective cohort studies. * **Recall Bias:** Common in Case-Control studies; **Selection Bias/Attrition** is more common in Cohort studies.

Question 298: Which of the following is true about the total fertility rate?

A. It is a sensitive indicator of family planning achievement.
B. It represents the completed family size. (Correct Answer)
C. It is the number of live births per 1000 married women in the reproductive age group.
D. It is the average number of girls born to a woman.

Explanation: ### Explanation **Total Fertility Rate (TFR)** is defined as the average number of children a woman would have if she were to pass through her reproductive years (15–49 years) experiencing the age-specific fertility rates (ASFR) of a given year. **Why Option B is correct:** TFR is considered the best single indicator of fertility. It represents the **completed family size** because it sums up the fertility patterns across all age groups of the reproductive period. Unlike the Crude Birth Rate, it is independent of the age structure of the population, making it a standardized measure of a woman's total reproductive output. **Analysis of Incorrect Options:** * **Option A:** The **Couple Protection Rate (CPR)** is the most sensitive indicator for monitoring the performance and achievements of family planning programs, not TFR. * **Option C:** This definition describes the **General Marital Fertility Rate (GMFR)**. TFR is calculated by summing the Age-Specific Fertility Rates (ASFR) and is usually expressed per woman, not per 1000. * **Option D:** The average number of *girls* born to a woman is the **Gross Reproduction Rate (GRR)**. TFR counts all live births regardless of sex. **High-Yield Pearls for NEET-PG:** * **Replacement Level Fertility:** A TFR of **2.1** is required for a population to exactly replace itself from one generation to the next. * **Current Status:** India has achieved a TFR of **2.0** (NFHS-5), which is below the replacement level. * **Net Reproduction Rate (NRR):** If NRR is **1**, it signifies that a woman is replaced by exactly one daughter; this is the demographic goal of India’s National Health Policy.

Question 299: How can confounding be removed or controlled in a study?

A. Assign confounding to both cases and controls
B. Stratification
C. Matching
D. All of the above (Correct Answer)

Explanation: **Explanation:** Confounding occurs when the relationship between an exposure and an outcome is distorted by a third variable (the confounder) that is associated with both. To ensure internal validity, researchers must control for these variables during either the **Design phase** or the **Analysis phase** of a study. 1. **Assigning confounding to both groups (Randomization):** By randomly assigning subjects, known and unknown confounders are distributed equally between cases and controls (or treatment and placebo groups). This neutralizes their effect. 2. **Matching (Design Phase):** This involves selecting controls who possess the same confounding characteristics (e.g., age, sex, smoking status) as the cases. This ensures the groups are comparable regarding the confounder. 3. **Stratification (Analysis Phase):** The data is divided into sub-groups (strata) based on the confounder. For example, analyzing the association between coffee and heart disease separately for "Smokers" and "Non-smokers" to remove the confounding effect of tobacco. Since all three methods are standard epidemiological techniques to eliminate bias, **Option D** is correct. **High-Yield NEET-PG Pearls:** * **Restriction:** Another design-phase method where you limit the study to only one category of a confounder (e.g., studying only non-smokers). * **Multivariate Analysis:** A statistical method (like Logistic Regression) used in the analysis phase to control for multiple confounders simultaneously. * **Randomization** is the only method that can control for **unknown** confounders. * **Matching** is most commonly used in Case-Control studies but can lead to "over-matching" if not done carefully.

Question 300: Which study design is used to study the natural history of a disease?

A. Cross-sectional study
B. Ecological study
C. Cohort study (Correct Answer)
D. Randomized controlled trial (RCT)

Explanation: **Explanation:** The **Cohort study** is the gold standard observational design for studying the **natural history of a disease**. In a cohort study, a group of individuals who are initially free of the disease are followed forward in time (prospective) to observe the transition from health to disease, complications, or recovery. This longitudinal approach allows researchers to calculate **Incidence** and observe the sequence of events, making it ideal for understanding how a disease progresses from exposure to outcome. **Analysis of Options:** * **A. Cross-sectional study:** This provides a "snapshot" of a population at a single point in time. It measures **prevalence**, not the progression of disease over time, making it unsuitable for studying natural history. * **B. Ecological study:** This uses **populations or groups** as the unit of study rather than individuals. It is used to generate hypotheses about correlations but cannot track the clinical course of a disease in individuals. * **D. Randomized Controlled Trial (RCT):** This is an **experimental** study used to test the efficacy of an intervention (drug/procedure). It does not study the "natural" history because the researcher actively intervenes in the disease process. **High-Yield Clinical Pearls for NEET-PG:** * **Incidence** can only be calculated from Cohort studies. * **Relative Risk (RR)** and **Attributable Risk (AR)** are the primary measures of association in Cohort studies. * Cohort studies are best for **rare exposures**, while Case-control studies are best for **rare diseases**. * The "Framingham Heart Study" is a classic example of a cohort study used to understand the natural history of cardiovascular disease.

Practice by Chapter

Principles of Epidemiology

Practice Questions

Measures of Disease Frequency

Practice Questions

Epidemiological Study Designs

Practice Questions

Descriptive Epidemiology

Practice Questions

Analytical Epidemiology

Practice Questions

Experimental Epidemiology

Practice Questions

Screening for Disease

Practice Questions

Surveillance Systems

Practice Questions

Investigation of an Epidemic

Practice Questions

Association and Causation

Practice Questions

Modern Epidemiological Methods

Practice Questions

Critical Appraisal of Epidemiological Studies

Practice Questions

Want unlimited practice?

Get full access to all questions, explanations, and performance tracking.

Start For Free